# Edwards Lifesciences to acquire CASMED for $100M

Edwards Lifesciences has entered into a definitive merger agreement to acquire CAS Medical Systems (CASMED) for $2.45 per share, or an equity value of approximately $100 million. The acquisition is expected to close in the second quarter of 2019.

- Type: Acquisition
- Announced: 2019-02-12
- Where: United States
- Value: $100.0M
- Status: announced
- Products: cerebral oximetry technology, hemodynamic monitoring platform
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Edwards Lifesciences](https://endata.com/companies/5656.md) (acquirer)
- [CAS Medical Systems](https://endata.com/companies/37251.md) (target)

## Sources

- [edwards.com](https://www.edwards.com/newsroom/news/2019-02-12-edwards-lifesciences-enters-into-agreement-to-acqu-a8a538d), 2019-02-12: "We believe the incorporation of CASMED's FORE-SIGHT technology into Edwards' leading hemodynamic monitoring platform will strengthen Edwards' leadership in smart monitoring technologies."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.